Webinar: Chalk Talk Update on Valvular Heart Disease

Tue, May 12, 2015
5:15pm to 6:15pm ET

Description

A Webinar on the Staging Classification of Valve Disease with Rick A. Nishimura, M.D. Moderated by Steve R. Ommen, M.D. ValveDiseaseWebinarSketches-1 ValveDiseaseWebinarSketches-1 ValveDiseaseWebinarSketches-1 ValveDiseaseWebinarSketches-1 ValveDiseaseWebinarSketches-1

Location

Online

is this recorded or archived for future viewing please?

REPLY
@mikehuq

is this recorded or archived for future viewing please?

Jump to this post

Hi, Mike. Yes! It is being recorded for future viewing.

REPLY

please comment on Fonseca article in JACC showing most clinicians do not follow guidelines? Also, has anyone looked to see if guidelines are followed, does it lead to improved outcomes? It seems the 'guidelines' are a little unscientific in their application and use.

REPLY

Symptomatic patient, 'moderate' gradient, but small stroke volume, moderate diastolic dysfunction, is dobutamine stress echo helpful ?

REPLY

Patients with Severe MR (Stage C and D) and Normal Systolic BP: will you recommend MV repair/replacement or adding after-load reducing agents such as ACE-Inhibitors/Hydralazine prior to intervention. guidelines say DO NOT add afterload reducing agents unless patient is hypertensive

REPLY

Work up and timing of interevention in paradoxical low flow low gradient AS?

REPLY

Could you please comment on management of symptomatic pt with low flow low gradient severe AS with PRESERVED LVF? Do you go more with the AVA or gradients? Any role for vasodilator challenge?

REPLY

The legal community is fully aware of these guidelines and uses them in support of their "cause of action" for their client/patients.

REPLY

in patients with AS, if there is Peak/Mean Gradient and AVA mismatch, what parameter do we pick to grade stenosis?

REPLY

when is the next Chalk Talk?

REPLY
Please sign in or register to post a reply.